The Efficacy and Safety of Dalpiciclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, in Patients with Advanced Head and Neck Mucosal Melanoma Harboring CDK4 Amplification
BMC MEDICINE（2024）
关键词
CDK4/6 inhibitor,Dalpiciclib,Head and neck mucosal melanoma,Clinical trial,CDK4 amplification
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要